Laura and Isaac Perlmutter Cancer Center at NYU Langone — Mineola, New York

Laura and Isaac Perlmutter Cancer Center at NYU Langone is a clinical research site located in Mineola, New York, United States 11501.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Laura and Isaac Perlmutter Cancer Center at NYU Langone has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Untreated, Unresectable, or Metastatic Colorectal Cancer, Pancreatic Ductal Adenocarcinoma.

Sponsors: Bristol-Myers Squibb.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Mineola

Browse all research sites in New York · View every site in Mineola

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Laura and Isaac Perlmutter Cancer Center at NYU Langone?

Laura and Isaac Perlmutter Cancer Center at NYU Langone has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Laura and Isaac Perlmutter Cancer Center at NYU Langone conducted?

Laura and Isaac Perlmutter Cancer Center at NYU Langone has 2 clinical trials on record, with 2 currently active. Their work covers Untreated, Unresectable, or Metastatic Colorectal Cancer, Pancreatic Ductal Adenocarcinoma.

Is Laura and Isaac Perlmutter Cancer Center at NYU Langone accredited by Crixeo Clinical Trials?

Laura and Isaac Perlmutter Cancer Center at NYU Langone has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Laura and Isaac Perlmutter Cancer Center at NYU Langone?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.